Almost 25 million prescription drug packs dispensed in Latvia this year
The Latvian Medicines Verification Organisation (LZVO) has compiled the performance indicators of the Latvian Medicines Verification System (LZVS) for the first ten months of 2025, including data on transactions carried out in the system, end users, alerts, and their most frequent causes.
There are two types of transactions with packs of medicinal products – one is verification of the authenticity of the unique identifier on that pack; the other is decommissioning of the pack from the system. In pharmacies and healthcare institutions unique identifiers are decommissioned from the system when the medicine is supplied to the public.
In the first ten months of 2025, the total number of transactions carried out in the LZVS reached 96 million. Of these, 24.6 million authentic packs of prescription medicine were dispensed to public through pharmacies and healthcare institutions.
The compiled data show that as of November 1, 2025, a total of 1168 users have connected to the LZVS — including pharmacies, hospital pharmacies, wholesalers, and healthcare institutions with a license to purchase medicines (such as hospitals, polyclinics, medical practices, and dental clinics). LZVO also provides access to the system for the State Agency of Medicines and the Health Inspectorate for market surveillance and investigation of suspected falsifications.
The proportion of alerts in Latvia during the first ten months of 2025 was 0.01% of total number of transactions, which can be assessed as a very good result. The European Medicines Verification Organisation has set a benchmark that the alert rate should not exceed 0.05%, and Latvia meets this operational target exemplary well. Data analysis indicates that alerts in Latvia are most often caused by technical errors in scanners and/or software operations, or by human error. Once these issues are corrected, the affected packs are successfully verified and decommissioned in the system.
In the first ten months of 2025, compared with the same period of the previous year, the number of alerts has not changed significantly, indicating stability in both system performance and the daily operations of end users.
Overall, the performance and operation of the system during this period can be assessed as stable and fully compliant with the requirements of the Delegated Regulation. LZVO has not received any reports of suspected falsification within the legal supply chain.
Thanks to the LZVS, prescription medicines dispensed in pharmacies and healthcare institutions are verified and authentic, ensuring that patients can feel confident the medicines they receive are genuine and contain the substances indicated on the packaging in the correct amounts.